After PCI searching for target lesion ischemia with intracoronary ECG will be performed and if found it will be treated pharmacologically
The study will include patients with coronary lesions and PCI. It will include patients with stable or unstable angina, without elevated hs-TnT. PCI will be performed and monitoring of intracoronary ST elevation. Any dissection or acute vessel closure will be promptly treated with balloon or stenting. Although there could be good angiographic result sometimes ischemia could be detected in the treated region by means of intracoronary ECG ST elevation above 1mm. This study aims to tackle this issue with randomization of the patients into three possible treatments - intracoronary adenosine, IIb/IIIa inhibitors or nitroglycerine alone - intracoronary ST segment will be searched for reverse or residual ischemia after the pharmacologic bolus. The intracoronary electrocardiography (i.c. ECG) is a very sensitive method for ischemia detection. The i.c. ECG reacts earlier on ischemia; the changes are much more prominent and easy to register. The wire tip could be positioned directly in different regions and thus to "map" regional ischemia. In most of the studies and from our own observations became evident that when surface ECG do not react the i.c. ECG demonstrates significant changes in ST-segment and QRS complex. Moreover, the registration of i.c. ECG is very cheap and needs only an adapter connecting coronary wire end and ECG. An i.c. ECG also can differentiate residual ischemic changes in distal main vessel and side branch as sources of prolonged ischemia, respectively - source of periprocedural myonecrosis. Once good angiographic result is obtained after stenting there could be different reasons for ischemia in the treated region - microembolic debris or coronary microvascular spasm.
Study Type
OBSERVATIONAL
Enrollment
60
Alexandrovska University Hospital
Sofia, Bulgaria
RECRUITINGIntracoronary ischemia change after intracoronary drug bolus
Look for ischemia change after intracoronary drugs
Time frame: 12 months
Target lesion revascularization
Any revascularization at the territory of previously implanted stent.
Time frame: 12 months
Number of patients not alive
death
Time frame: 12 months
Myocardial infarction
MI after discharge
Time frame: 12 months
New onset angina or heart failure symptoms
New onset angina symptoms of at least CCS class II; New onset dyspnea at exertion or at rest
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.